Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Mears Group acquires Care UK’s domiciliary care service for £11.3m

Support services firm Mears Group has bought Care UK’s home care division, as was first reported by HealthInvestor, for a sum of £11.3 million.

The purchase price comprises of a base payment of £9 million with a further payment of £2.3 million made in respect of cash balances and excess working capital acquired on completion.

Care UK’s home care service looks after approximately 13,000 people across the UK and employs around 6,000 staff members.

For the year ended 30 September 2014, it reported revenues of £72.2 million and an operating loss before exceptional items of £2.6 million.

In a statement, Mears said Care UK had already started closing some branches of the domiciliary care business because of “particularly poor results in certain regions”.

The acquired assets will be renamed Mears Care and the management team will remain the same.

David Miles, chief executive of Mears Group (pictured), said: "I believe we have acquired one of our most significant competitors at an attractive valuation. Our focus will be upon enhancing service delivery thus enabling financial improvements.”

The acquisition  marks the completion of Care UK’s divestment strategy, which also saw it sell off its mental health and learning disability divisions. The private care provider has said it plans focus solely primary and secondary NHS health services and residential and nursing homes.

In May, Care UK sold its mental health assets, comprising of 322 beds, to Partnerships in Care for an undisclosed sum. It also sold its learning disability services group to Lifeways in the same month.

According to a press release, the three transactions, which had a combined annual ebitda of £12.9 million last year, have generated £130 million (before fees and expenses) for Care UK.

Mike Parish, chief executive of Care UK, said: “We are pleased to have reached very positive outcomes for patients and services users, colleagues and commissioners in all three services. The strategic review process which is now completed strengthens Care UK’s positioning for future growth within both the health and social care sectors.”

Rothschild advised Care UK on its divestments.


Related articles:

Posted on: 01/06/2015

Latest news stories

22/03/2019
A report by the National Audit Office has raised concerns over the lack of capacity in the NHS and resulting increase in waiting times for patients.
22/03/2019
Civitas Social Housing has acquired properties worth £85.6 million.
22/03/2019
VPS Healthcare, an Abu Dhabi-based hospital operator, is reconsidering plans to list on London Stock Exchange due to uncertainty surrounding Britain’s EU exit.
21/03/2019
The UK’s largest private healthcare provider is closing two of its hospitals and selling a third to the NHS.
21/03/2019
Healthcare software provider EMIS Group has reported growth in turnover and operating profit in its final results for the year ended 31 December 2018.


Civica


HealthInvestor blog
The chaos around the UK leaving the EU continues apace but healthcare investment is steering a steady course through the storm

Click here to view the HealthInvestor blog


A manufacturing aficionado intrigued by the possibilities tech offers to revolutionise health delivery and positively impact lives
abc ivf is offering IVF treatment at prices well below the industry average, suggesting it may have developed a winning formula – but are they cutting corners or is everyone else missing a trick, and what could it mean for the IVF sector and patients in future? Jeremy Bowden investigates
Where are the opportunities in care homes and retirement living? Carterwood’s director Tom Hartley and principal analyst Aishling Barrett analyse the sector’s supply and demand
Private equity interest in medical devices is growing. Catherine Gooderham takes a look at this complex and diverse market
The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion

Click here to search all feature articles



The private hospital sector

The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion
Read more


Christie + Co

my images



Company profile: Montreux Capital Management

The healthcare sector continues to evolve and it's the innovators that will shape its future. Marie Cahalane caught up with Oliver Harris, founder and chief executive of Montreux Capital Management, and quizzed him about his company's active approach to investment
Read more